Cybin (HELP) Operating Expenses (2020 - 2025)
Cybin (HELP) reported Operating Expenses of $17771.4 for Q2 2025, up 63.69% on a YoY basis from $10856.7 in Q2 2024, and down 99.98% quarter-over-quarter from $99.7 million in Q1 2025.
Cybin (HELP) Operating Expenses (2020 - 2025) Analysis & Trends
Cybin has reported Operating Expenses for 6 years, with the latest figure at $17771.4 in Q2 2025.
- For the quarter ending Q2 2025, Operating Expenses rose 63.69% year-over-year to $17771.4; the trailing twelve-month figure through Jun 2025 stood at $142.4 million (up 106.8% YoY), and the FY2025 full-year result was $103.0 million, up 76.01% from the prior year.
- Operating Expenses for Q2 2025 stood at $17771.4, down from $99.7 million in the prior quarter.
- The five-year high for Operating Expenses was $99.7 million in Q1 2025, with the low at -$16.9 million in Q1 2023.
- Historically, Operating Expenses has averaged $16.1 million across 5 years, with a median of $9.5 million in 2023.
- Annual changes were most pronounced in 2021 — Operating Expenses jumped 607.09% — and 2024, when it plunged 99.89%.
- Cybin's Operating Expenses stood at $13.1 million in 2021, then plunged by 31.75% to $8.9 million in 2022, then plunged by 99.78% to $19850.1 in 2023, then increased by 12.89% to $22408.9 in 2024, then decreased by 20.69% to $17771.4 in 2025.
- The last three Operating Expenses figures came in at $17771.4 (Q2 2025), $99.7 million (Q1 2025), and $22408.9 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | 17,771.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 17,771.45 |
| Mar 31, 2025 | 99.68 Mn |
| Dec 31, 2024 | 22,408.94 |
| Sep 30, 2024 | 42.70 Mn |
| Jun 30, 2024 | 10,856.71 |
| Mar 31, 2024 | 58.47 Mn |
| Dec 31, 2023 | 19,850.09 |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 9.46 Mn |
| Feb 28, 2023 | -16.88 Mn |
| Dec 31, 2022 | 8.91 Mn |
| Sep 30, 2022 | 9.45 Mn |
| May 31, 2022 | 4.55 Mn |
| Dec 31, 2021 | 13.05 Mn |
| Sep 30, 2021 | 13.59 Mn |
| Jun 30, 2021 | 11.34 Mn |
| Mar 31, 2021 | 9.77 Mn |
| Dec 31, 2020 | 8.73 Mn |
| Sep 30, 2020 | 1.92 Mn |
| Jun 30, 2020 | 3.19 Mn |